Caricamento...
Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
Pancreatic adenocarcinoma (PDAC) has a grim prognosis. Molecular and genomic analyses revealed that the striking majority of these tumors are driven by KRAS mutation, currently not amenable to targeted therapy. However, other driver mutations were found in a small fraction of patients. Herein we rep...
Salvato in:
| Pubblicato in: | Case Rep Oncol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
S. Karger AG
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6381925/ https://ncbi.nlm.nih.gov/pubmed/30792639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496018 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|